Biocryst Pharmaceuticals reported $395.5M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
DBV Technologies DBVT:US 44.96M 912K
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Biocryst Pharmaceuticals BCRX:US $ 395.5M 108.88M
Chemocentryx CCXI:US $ 40.58M 9.4M
Chugai Pharma 4519:JP Y 230474M 37279M
Daiichi Sankyo 4568:JP Y 662477M 85182M
Enanta Pharmaceuticals ENTA:US $ 40.99M 58.08M
Gilead Sciences GILD:US $ 4296M 1042M
Glaxosmithkline GSK:US $ 10967M 6693M
GlaxoSmithKline GSK:LN 10967M 6693M
Intra Cellular Therapies ITCI:US $ 129.29M 36.93M
IONIS PHARMACEUT IONS:US $ 542.51M 326.68M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Neurocrine Biosciences NBIX:US $ 270.2M 70.6M
Novavax NVAX:US $ 1570.95M 1209.13M
Ptc Therapeutics PTCT:US $ 144.18M 45.54M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Sarepta Therapeutics SRPT:US $ 1233.88M 881.99M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Vertex Pharmaceuticals VRTX:US $ 7600.1M 805.1M
YTE INCY:US $ 2256.76M 199.32M